YaSheng : Annual Report

2020 -

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

YASHENG GROUP

2245 Fortune Dr # C, San Jose, CA 95131

_______________________________

5108604685

www.yashenggroup.com

[e-mail]

100

Annual Report

For the Periods Ending: 2021 and 2020

(the "Reporting Period")

As of the current reporting date of December 31 2021, the number of shares outstanding of our Common Stock was: [157,165,783]

As of the prior reporting date of September 30, 2021, the number of shares outstanding of our Common Stock was: [157,165,783]

As of the most recent completed fiscal year end date of December 31, 2020,, the number of shares outstanding of our Common Stock was:

[157,165,783]

Indicate	by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and
Rule 12b-2 of the Exchange Act of 1934):
Yes: ☐	No: ☒
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐	No: ☒
Indicate by check mark whether a Change in Control5 of the company has occurred over this reporting period:
Yes: ☐	No: ☒

5 "Change in Control" shall mean any events resulting in:

1. Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act),

directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;

1. The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
2. A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
3. The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting

securities	of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the
surviving	entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent

outstanding immediately after such merger or consolidation.

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3. 1 June 24, 2021)	Page 4 of 12

1. Name and address(es) of the issuer and its predecessors (if any)

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

YaSheng Group

2245 Fortune Dr # C, San Jose, CA 95131

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

Colorado, Active

On March 15, 2021, Yasheng Group ("HERB") entered into an Agreement and Plan of Merger (the "Merger Agreement"), by and among itself and its wholly owned subsidiary, Yasheng Group, a Colorado corporation wherein Yasheng Group merged into its wholly owned subsidiary changing home state of jurisdiction of Yasheng Group from California to Colorado. No other changes to corporation occurred maintaining the same assets, management, bylaws, authorized capital and issued and outstanding shares. No actions were required to be taken by shareholders as result of this change in venue. The change in domicile became effective June 21 2021 witnessed in the attached exhibit entitled "Statement of Merger" attached in the company's 8k filed with the SEC.

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

none

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

FINRA did not approve that shareholders would receive 1 share of Equity Art Corp Ltd as of the record date of September 15，2021 for each share held on that date since HERB is not a current reporting issuer. HERB may set a new record date should a form 10 be filed and become effective or distribute EQRFT as a restricted dividend prior to once again achieving current reporting status.

The address(es) of the issuer's principal executive office:

2245 Fortune Dr # C, San Jose, CA 95131

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address: ☒

Address: 21 YanXing Rd. Yasheng Mansion 10-15,

Chengguan District, Lanzhou, China

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes: ☐

No: ☒

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

1. Security Information

OTC	Markets Group Inc.
OTC	Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 5 of 12

Trading symbol:

Exact title and class of securities outstanding:

CUSIP:

Par or stated value:

Total shares authorized: Total shares outstanding:

Number of shares in the Public Float6: Total number of shareholders of record:

HERB Common98508U104 $1

800,000,000as of date: December /31/ 2021

157,165,783as of date: December /31/ 2021

14,012,409 as of date: December /31/ 2021

331as of date: December/31/2021

All additional class(es) of publicly traded securities (if any):

Trading symbol:

Exact title and class of securities outstanding:

CUSIP:

Par or stated value:

Total shares authorized:

Total shares outstanding:

Transfer Agent

December

as of date: as of date:

Name:	Transfer Online, Inc.
Phone:	503.227.2950
Email:	[e-mail]
Address:	444 SW 5th Ave,Portland, OR 97204
Is the Transfer Agent registered under the Exchange Act?7 Yes: ☒	No: ☐

1. Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☒

6 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial

owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.

7 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

OTC	Markets Group Inc.
OTC	Pink Basic Disclosure Guidelines (v3. 1 June 24, 2021)	Page 6 of 12

Shares Outstanding as of Second Most Recent

Fiscal Year End:

*Right-click the rows below and select "Insert" to add rows as needed.

Opening Balance

Date

Common:

Preferred:

Date of

Transaction

Number of

Class of

Value of

Were the

Individual/ Entity

Reason for share

Restricted or

Exemption

Transaction

type (e.g. new

Shares

Securities

shares

shares

Shares were

issuance (e.g. for

Unrestricted

or

issuance,

Issued (or

issued

issued at

issued to

cash or debt

as of this

Registration

cancellation,

cancelled)

($/per

a discount

(entities must

conversion)

filing.

Type.

shares

share) at

to market

have individual

-OR-

returned to

Issuance

price at

with voting /

Nature of

treasury)

the time

investment

Services

of

control

Provided

issuance?

disclosed).

(Yes/No)

Shares Outstanding on Date of This Report:

Ending

Balance

Ending Balance:

Date

Common:

Preferred:

Example: A company with a fiscal year end of December 31st , in addressing this item for its quarter ended June 30, 2021, would

include

any events that resulted in changes to any class of its outstanding shares from the period beginning on January 1, 2019 through

June 30, 2021 pursuant to the tabular format above.

Use the space below to provide any additional details, including footnotes to the table above:

B. Debt Securities, Including Promissory and Convertible Notes

Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.

Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☒

Date of	Outstanding	Principal	Interest	Maturity	Conversion Terms (e.g.	Name of Noteholder	Reason for
Note	Balance ($)	Amount	Accrued	Date	pricing mechanism for	(entities must have	Issuance (e.g.
Issuance		at	($)		determining conversion of	individual with voting	Loan, Services,
		Issuance			instrument to shares)	/ investment control	etc.)
		($)				disclosed).

OTC	Markets Group Inc.
OTC	Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 7 of 12